CompletedNot Applicable

Pulmonary Rehabilitation and Quality of Life in Children With Chronic Lung Diseases: A Multidisciplinary Approach

Egypt400 participantsStarted 2022-11-01

Plain-language summary

Chronic lung diseases (CLDs) such as asthma, cystic fibrosis, and bronchopulmonary dysplasia significantly impact pediatric patients' respiratory function and overall well-being. Pulmonary rehabilitation (PR) has been shown to improve lung function, exercise tolerance, and quality of life in affected individuals. However, limited research has been conducted on PR implementation in Egypt.

Who can participate

Age range6 Years – 16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed cases of CLDs, stable clinical condition, and ability to participate in rehabilitation. Exclusion Criteria: * Severe comorbidities, recent respiratory infections, or contraindications to physical activity.

What they're measuring

Forced Expiratory Volume in One Second

Timeframe: at basline and after 12-weeks of intervention

Forced Vital Capacity

Timeframe: at basline and after 12-weeks of intervention

Peak Expiratory Flow Rate

Timeframe: at basline and after 12-weeks of intervention

Trial details

NCT IDNCT06870032

SponsorHorus University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-11-15

View on ClinicalTrials.gov More Chronic Lung Disease trials